HAVCR2 and neoplasm: The enhanced Tim‐3 siRNA can inhibit tumor cell growth by inducing immune responses and recruiting CTLs, whereas the SF@PP NM releases Sor at lower pH, blocking tumor proliferation and angiogenesis.